MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Ownership - Who owns Neurogene?
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning)... Show more
Profile
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
163.87M
P/E Ratio
N/A
Total Cash
138.99M
Projected Growth
N/A
Total Debt
14.53M
Revenue
925K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.75
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
NGNE
Capitalization
164M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
139M
Total Cash/Share
9.75
Total Debt
14.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
925K
ROE
N/A
Book Value
137M
P/B Ratio
0.53
Cash Flow
N/A
Earnings
-4.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
9.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-49.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.44
Shares Held By Institutions
551M
Shares Outstanding - Current
14.3M
Total Liabilities
26.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-49.738
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com